+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 43 Pages
  • September 2023
  • GlobalData
  • ID: 1957485
SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SMS Pharmaceuticals Ltd (SMS Pharma) manufactures active pharmaceutical ingredients (APIs) and intermediates. The company offers APIs for anti-fungal, anti-migraine, anti-ulcer, anti-hypersensitive, anti-psychotic, anti-viral, and other products. It provides contract research and manufacturing services. The company exports its products in multiple countries. It has manufacturing facilities in Bachupally, Telangana; and Kandivalasa, Andhra Pradesh. The company also has an R&D center in Hyderabad, Telangana. SMS Pharma is headquartered in Hyderabad, Telangana, India.

SMS Pharmaceuticals Ltd Key Recent Developments

  • Sep 07023: SMS Pharmaceuticals : Business Responsibility and Sustainability Report for the Financial Year 2022-23
  • Sep 07023: SMS Pharmaceuticals : Notice of 35TH Annual General Meeting and Annual Report for the FY 2022-2023
  • Nov 12022: SMS Pharmaceuticals announces Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022
  • Mar 21022: USFDA completes remote regulatory assessment of analytical testing facility of SMS Pharmaceuticals

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • SMS Pharmaceuticals Ltd - Key Facts
  • SMS Pharmaceuticals Ltd - Key Employees
  • SMS Pharmaceuticals Ltd - Key Employee Biographies
  • SMS Pharmaceuticals Ltd - Major Products and Services
  • SMS Pharmaceuticals Ltd - History
  • SMS Pharmaceuticals Ltd - Company Statement
  • SMS Pharmaceuticals Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • SMS Pharmaceuticals Ltd - Business Description
  • R&D Overview
  • SMS Pharmaceuticals Ltd - Corporate Strategy
  • SMS Pharmaceuticals Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • SMS Pharmaceuticals Ltd - Strengths
  • SMS Pharmaceuticals Ltd - Weaknesses
  • SMS Pharmaceuticals Ltd - Opportunities
  • SMS Pharmaceuticals Ltd - Threats
  • SMS Pharmaceuticals Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • SMS Pharmaceuticals Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 07, 2023: SMS Pharmaceuticals : Business Responsibility and Sustainability Report for the Financial Year 2022-23
  • Sep 07, 2023: SMS Pharmaceuticals : Notice of 35TH Annual General Meeting and Annual Report for the FY 2022-2023
  • Nov 12, 2022: SMS Pharmaceuticals announces Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022
  • Mar 21, 2022: USFDA completes remote regulatory assessment of analytical testing facility of SMS Pharmaceuticals
  • Mar 17, 2022: 35 generic manufacturers sign agreements with MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for supply in 95 low- and middle-income countries
  • Feb 09, 2022: SMS Pharmaceuticals Announces Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • SMS Pharmaceuticals Ltd, Key Facts
  • SMS Pharmaceuticals Ltd, Key Employees
  • SMS Pharmaceuticals Ltd, Key Employee Biographies
  • SMS Pharmaceuticals Ltd, Major Products and Services
  • SMS Pharmaceuticals Ltd, History
  • SMS Pharmaceuticals Ltd, Other Locations
  • SMS Pharmaceuticals Ltd, Key Competitors
  • SMS Pharmaceuticals Ltd, Ratios based on current share price
  • SMS Pharmaceuticals Ltd, Annual Ratios
  • SMS Pharmaceuticals Ltd, Interim Ratios
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • SMS Pharmaceuticals Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • SMS Pharmaceuticals Ltd, Performance Chart (2019 - 2023)
  • SMS Pharmaceuticals Ltd, Ratio Charts
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Gary Pharmaceuticals Pvt Ltd
  • Aarti Drugs Ltd
  • J B Chemicals and Pharmaceuticals Ltd
  • Gayatri Herbals PvtLtd
  • Southern Petrochemical Industries Corp Ltd
  • Gayatri Herbals PvtLtd
  • Gary Pharmaceuticals Pvt Ltd
  • J B Chemicals and Pharmaceuticals Ltd
  • Aarti Drugs Ltd
  • Southern Petrochemical Industries Corp Ltd